Patents by Inventor Jingjing Peng

Jingjing Peng has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pyrimidine Heterocyclic Compound, Preparation Method Thereof and use Thereof in Medicine
    Publication number: 20250145632
    Abstract: The present invention discloses a pyrimidine heterocyclic compound, and a preparation method and medical use thereof. Specifically, the present invention discloses a pyrimidine heterocyclic compound with a structure shown in Formula (A) or a pharmaceutically acceptable salt thereof (groups are each defined in the specification), a pharmaceutical composition comprising the compound, and use of the compound in treatment of cell proliferative diseases (such as cancers).
    Type: Application
    Filed: December 21, 2022
    Publication date: May 8, 2025
    Inventors: Hongfu LU, Jingjing PENG, Xiao DING, Jinxin LIU, Yingtao LIU, Feng REN, Fusheng ZHOU, Tao JIANG, Tao LIANG, Jiong LAN, Qiang LU
  • Ketoamide compound and preparation method, pharmaceutical composition, and use thereof
    Patent number: 12152017
    Abstract: A ketoamide compound and a preparation method, a pharmaceutical composition, and a use thereof. Specifically, the ketoamide compound shown in formula (A), a racemate, an enantiomer, or a diastereoisomer thereof, or any mixture of same, or a pharmaceutically active metabolite thereof, or a pharmaceutically acceptable salt, solvate, or prodrug thereof. The ketoamide compound can effectively inhibit coronavirus or Ebola virus, and thereby implement the prevention or treatment of diseases related to coronavirus or diseases related to Ebola virus.
    Type: Grant
    Filed: August 9, 2019
    Date of Patent: November 26, 2024
    Assignees: Shanghai Institute of Materia Medica, Chinese Academy of Sciences, Fudan University
    Inventors: Hong Liu, Shibo Jiang, Wenhao Dai, Lu Lu, Jingjing Peng, Shuai Xia, Jiang Wang, Jian Li, Hualiang Jiang, Kaixian Chen
  • SARS-COV-2 INHIBITORS FOR TREATING CORONAVIRUS INFECTIONS
    Publication number: 20240025860
    Abstract: Provided herein are compounds, pharmaceutical compositions, and methods for treating a SARS-CoV-2 infection.
    Type: Application
    Filed: June 22, 2023
    Publication date: January 25, 2024
    Inventors: Xiao DING, Jingjing PENG, Feng REN, Xiaoyu DING, Bogdan ZAGRIBELNYY, Yan A. IVANENKOV
  • SARS-CoV-2 inhibitors for treating coronavirus infections
    Patent number: 11731944
    Abstract: Provided herein are compounds, pharmaceutical compositions, and methods for treating a SARS-CoV-2 infection.
    Type: Grant
    Filed: February 8, 2023
    Date of Patent: August 22, 2023
    Assignee: Insilico Medicine IP Limited
    Inventors: Xiao Ding, Jingjing Peng, Feng Ren, Xiaoyu Ding, Bogdan Zagribelnyy, Yan A. Ivanenkov
  • SARS-COV-2 INHIBITORS FOR TREATING CORONAVIRUS INFECTIONS
    Publication number: 20230192624
    Abstract: Provided herein are compounds, pharmaceutical compositions, and methods for treating a SARS-CoV-2 infection.
    Type: Application
    Filed: February 8, 2023
    Publication date: June 22, 2023
    Inventors: Xiao DING, Jingjing PENG, Feng REN, Xiaoyu DING, Bogdan ZAGRIBELNYY, Yan A. IVANENKOV
  • PHARMACEUTICAL USE OF ALDEHYDE-BASED COMPOUND
    Publication number: 20230138310
    Abstract: Use of an aldehyde-based compound as represented by general formula I, a pharmaceutical composition, a pharmaceutical salt, an enantiomer, a diastereomer and a racemic compound thereof as a novel coronavirus 2019 (2019-nCov) 3CL protease inhibitor in preparation of a medicament for treating and/or preventing and relieving respiratory tract infections, pneumonia and other related diseases caused by the novel coronavirus infection 2019.
    Type: Application
    Filed: March 26, 2020
    Publication date: May 4, 2023
    Inventors: Hong LIU, Jian LI, Wenhao DAI, Jingjing PENG, Xiong XIE, Shulei HU, Chunpu LI, Yechun XU, Haitao YANG, Leike ZHANG, Haixia SU, Hualiang JIANG, Zhenming JIN, Gengfu XIAO, Kaixian CHEN
  • PHARMACEUTICAL USE OF KETOAMIDE-BASED COMPOUND
    Publication number: 20230133600
    Abstract: A class of ketoamide-based compounds, in particular, a ketoarnide-based compound as represented by general formula A is provided. The ketoamide compound may be used as a 2019 novel coronavirus (2019-nCov) 3 CL protease inhibitor and/or human cathepsin L inhibitor, and/or may be used in the preparation of a medicament for treating and/or preventing and relieving respiratory tract infection, pneumonia and other related diseases caused by 2019 novel coronavirus infection. Pharmaceutical compositions of the class of compounds, pharmaceutical salts, enantiomeric forms, diastereoisomers and racemic compounds thereof in the preparation of a medicament for treating and/or preventing and relieving respiratory tract infections and other related diseases caused by the 2019 novel coronavirus infection are also provided.
    Type: Application
    Filed: January 28, 2021
    Publication date: May 4, 2023
    Inventors: Hong LIU, Jian LI, Jingjing PENG, Xiong XIE, Wenhao DAI, Shulei HU, Chunpu LI, Leike ZHANG, Zhenming JIN, Yechun XU, Gengfu XIAO, Haitao YANG, Fang BAI, Xi CHENG, Hualiang JIANG, Kaixian CHEN
  • KETOAMIDE COMPOUND AND PREPARATION METHOD, PHARMACEUTICAL COMPOSITION, AND USE THEREOF
    Publication number: 20220112177
    Abstract: A ketoamide compound and a preparation method, a pharmaceutical composition, and a use thereof. Specifically, the ketoamide compound shown in formula (A), a racemate, an enantiomer, or a diastereoisomer thereof, or any mixture of same, or a pharmaceutically active metabolite thereof, or a pharmaceutically acceptable salt, solvate, or prodrug thereof. The ketoamide compound can effectively inhibit coronavirus or Ebola virus, and thereby implement the prevention or treatment of diseases related to coronavirus or diseases related to Ebola virus.
    Type: Application
    Filed: August 9, 2019
    Publication date: April 14, 2022
    Inventors: Hong Liu, Shibo Jiang, Wenhao Dai, Lu Lu, Jingjing Peng, Shuai Xia, Jiang Wang, Jian Li, Hualiang Jiang, Kaixian Chen